These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 457492)

  • 21. [Radiation-induced larynx perichondritis].
    Theissing J; Jung H
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1972; 201(4):324-31. PubMed ID: 5073718
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of advanced glottic cancer. A 10 year review of the Toronto experience.
    Harwood AR; Hawkins NV; Beale FA; Rider WD; Bryce DP
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):899-904. PubMed ID: 500417
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic factor of telecobalt therapy for early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Cancer; 1992 Dec; 70(12):2797-801. PubMed ID: 1451057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definitive radiotherapy in the management of stage I and II carcinomas of the glottis.
    Kelly MD; Hahn SS; Spaulding CA; Kersh CR; Constable WC; Cantrell RW
    Ann Otol Rhinol Laryngol; 1989 Mar; 98(3):235-9. PubMed ID: 2923399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electron beam treatment of early glottic lesions.
    Soni SC; Khan FR; Ovadia J; Nickson JJ
    J Radiol Electrol Med Nucl; 1974; 55(6-7):481-3. PubMed ID: 4214457
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose response in radiotherapy for glottic carcinoma.
    Karim AB; Snow GB; Hasman A; Chang SC; Keilholtz A; Hoekstra F
    Cancer; 1978 May; 41(5):1728-32. PubMed ID: 417795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Telecobaltotherapy of glottic and subglottic cancers].
    Bataini JP; Ennuyer A
    J Radiol Electrol Med Nucl; 1971 Nov; 52(11):753-4. PubMed ID: 5146868
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiotherapy of the larynx.
    Brand WN; Moss WT
    Otolaryngol Clin North Am; 1970 Oct; 3(3):581-8. PubMed ID: 4938161
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of the size of the fraction dose on normal and tumour tissue in 60 Co radiation treatment of carcinoma of the larynx and inoperable carcinoma of the breast.
    Kok G
    Radiol Clin Biol; 1971; 40(2):100-15. PubMed ID: 5113755
    [No Abstract]   [Full Text] [Related]  

  • 31. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
    Sert F; Karakoyun-Çelik O; Esassolak MA
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
    Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilemma of delayed radiation injury of the larynx.
    Calcaterra TC; Stern F; Ward PH
    Ann Otol Rhinol Laryngol; 1972 Aug; 81(4):501-7. PubMed ID: 4626646
    [No Abstract]   [Full Text] [Related]  

  • 36. Variations in radiation treatment for laryngeal cancer.
    Rubin P; Keller B
    Laryngoscope; 1975 Jun; 85(6):1004-23. PubMed ID: 1142966
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality control in planning and technique of radiotherapy with cobalt-60 for T1 glottic cancer increase local control and organ preservation.
    Cortes-Arroyo H; Rodríguez-Cuevas S; Labastida S
    Am J Surg; 1997 Nov; 174(5):477-80. PubMed ID: 9374218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation study of high-dose-rate brachytherapy for early glottic cancer.
    Hoffman MR; McCulloch TM; Mohindra P; Das R; Geurts M; Harari PM
    Brachytherapy; 2016; 15(1):94-101. PubMed ID: 26614234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.